Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app
- PMID: 33741586
- PMCID: PMC7978420
- DOI: 10.1126/sciadv.abd4177
Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app
Abstract
As no one symptom can predict disease severity or the need for dedicated medical support in coronavirus disease 2019 (COVID-19), we asked whether documenting symptom time series over the first few days informs outcome. Unsupervised time series clustering over symptom presentation was performed on data collected from a training dataset of completed cases enlisted early from the COVID Symptom Study Smartphone application, yielding six distinct symptom presentations. Clustering was validated on an independent replication dataset between 1 and 28 May 2020. Using the first 5 days of symptom logging, the ROC-AUC (receiver operating characteristic - area under the curve) of need for respiratory support was 78.8%, substantially outperforming personal characteristics alone (ROC-AUC 69.5%). Such an approach could be used to monitor at-risk patients and predict medical resource requirements days before they are required.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Figures




Similar articles
-
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5. Trials. 2021. PMID: 34158099 Free PMC article.
-
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5. Trials. 2021. PMID: 34635140 Free PMC article.
-
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1. Lancet Infect Dis. 2022. PMID: 34480857 Free PMC article.
-
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Jul 22;7:CD013705. doi: 10.1002/14651858.CD013705.pub3. PMID: 33760236 Free PMC article. Updated.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Nov 17;11:CD013652. doi: 10.1002/14651858.CD013652.pub2. PMID: 32584464 Free PMC article. Updated.
Cited by
-
Patient Self-Report Superior to Electronic Medical Record Abstraction for Identifying Positive COVID-19 Symptoms at Illness Onset.AJPM Focus. 2022 Sep;1(1):100005. doi: 10.1016/j.focus.2022.100005. Epub 2022 May 12. AJPM Focus. 2022. PMID: 36942014 Free PMC article.
-
Resistance training and clinical status in patients with postdischarge symptoms after COVID-19: protocol for a randomized controlled crossover trial "The EXER-COVID Crossover Study".Trials. 2022 Aug 9;23(1):643. doi: 10.1186/s13063-022-06608-y. Trials. 2022. PMID: 35945634 Free PMC article.
-
A Machine Learning Approach as an Aid for Early COVID-19 Detection.Sensors (Basel). 2021 Jun 18;21(12):4202. doi: 10.3390/s21124202. Sensors (Basel). 2021. PMID: 34207437 Free PMC article.
-
Factors associated with COVID-19 viral and antibody test positivity and assessment of test concordance: a retrospective cohort study using electronic health records from the USA.BMJ Open. 2021 Oct 1;11(10):e051707. doi: 10.1136/bmjopen-2021-051707. BMJ Open. 2021. PMID: 34598988 Free PMC article.
-
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms.PLoS One. 2023 Feb 9;18(2):e0281272. doi: 10.1371/journal.pone.0281272. eCollection 2023. PLoS One. 2023. PMID: 36757946 Free PMC article.
References
-
- Emanuel E. J., Persad G., Upshur R., Thome B., Parker M., Glickman A., Zhang C., Boyle C., Smith M., Phillips J. P., Fair allocation of scarce medical resources in the time of Covid-19. N. Engl. J. Med. 382, 2049–2055 (2020). - PubMed
-
- Phua J., Weng L., Ling L., Egi M., Lim C. M., Divatia J. V., Shrestha B. R., Arabi Y. M., Ng J., Gomersall C. D., Nishimura M., Koh Y., Du B.; Asian Critical Care Clinical Trials Group , Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations. Lancet Respir. Med. 8, 506–517 (2020). - PMC - PubMed
-
- Menni C., Valdes A. M., Freidin M. B., Sudre C. H., Nguyen L. H., Drew D. A., Ganesh S., Varsavsky T., Cardoso M. J., El-Sayed Moustafa J. S., Visconti A., Hysi P., Bowyer R. C. E., Mangino M., Falchi M., Wolf J., Ourselin S., Chan A. T., Steves C. J., Spector T. D., Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat. Med. 26, 1037–1040 (2020). - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials